These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Colony formation of CFU-MK and other hemopoietic progenitors in patients with acute non-lymphoblastic leukemia at diagnosis and following complete remission.
    Author: Chen Y, Li P, Lin B, Zhang G, Ruan C.
    Journal: Nouv Rev Fr Hematol (1978); 1989; 31(3):183-6. PubMed ID: 2616265.
    Abstract:
    Blood and marrow mononuclear cells were cultured in methylcellulose and plasma clot. In patients with acute non-lymphoblastic leukemia (ANLL) at diagnosis, marrow multipotential progenitors (CFU-Mix), megakaryocyte progenitors (CFU-MK) and granulocyte-monocyte progenitors (CFU-GM) were reduced or undetectable (all p less than 0.01). Two to 4 weeks after completion of induction therapy, marrow CFU-Mix returned to normal level (p greater than 0.05), CFU-MK and CFU-GM reached levels significantly higher than normal controls (both p less than 0.01), and circulating CFU-Mix, CFU-MK and CFU-GM were about 3, 6 and 6 times normal controls respectively (all p less than 0.01). During maintenance therapy CFU-Mix remained in low normal range (p greater than 0.05) and CFU-MK and CFU-GM were significantly reduced (both p less than 0.01). In patients at relapse CFU-Mix was undetectable (p less than 0.01) and CFU-MK and CFU-GM were undetectable or reduced (both p less than 0.01). The percentages of CFU-MK and CFU-GM in cell cycle S-phase as analysed by ara-c suicide technique were 51.4 +/- 5.8 and 52.3 +/- 2.3 two weeks after the completion of induction therapy, and 61.1 +/- 7.9 and 53.8 +/- 8.7 during maintenance therapy, all significantly higher than normal controls (all p less than 0.01). Our results suggest that chemotherapy may not result in severe damage to CFU-Mix, and that cell culture technique may be helpful in assessing prognosis.
    [Abstract] [Full Text] [Related] [New Search]